NF-κB activation is required for the development of cardiac hypertrophy in vivo

In the present study, we examined whether NF-κB activation is required for cardiac hypertrophy in vivo. Cardiac hypertrophy in rats was induced by aortic banding for 1, 3, and 5 days and 1–6 wk, an...

[1]  David L. Williams,et al.  Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection. , 2004, Cardiovascular research.

[2]  Y. Ahn,et al.  A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.

[3]  J. Molkentin,et al.  Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? , 2003, Circulation.

[4]  M. Kitagawa,et al.  Evidence that reactive oxygen species do not mediate NF‐κB activation , 2003 .

[5]  A. Lin,et al.  Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .

[6]  R. Hajjar,et al.  Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. , 2002, Physiological genomics.

[7]  P. Kang,et al.  Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.

[8]  M. Hori,et al.  Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. , 2002, Journal of molecular and cellular cardiology.

[9]  Yasushi Matsumura,et al.  Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.

[10]  Y. Zou,et al.  Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. , 2001, Biochemical and biophysical research communications.

[11]  Richard T. Lee,et al.  Peroxisome Proliferator-Activated Receptor &ggr; Activators Inhibit Cardiac Hypertrophy in Cardiac Myocytes , 2001, Circulation.

[12]  A. Lin,et al.  Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  David L. Williams,et al.  Early activation of IKKβ during in vivo myocardial ischemia , 2001 .

[14]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[15]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[16]  P. Kang,et al.  The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.

[17]  R. Passier,et al.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.

[18]  Paul A. Overbeek,et al.  TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.

[19]  R. Kao,et al.  Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. , 2000, Surgery.

[20]  D. Gardner,et al.  Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. , 1999, The Journal of clinical investigation.

[21]  R. Medzhitov,et al.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. , 1999, The Journal of clinical investigation.

[22]  C. Kim,et al.  Zinc is required in pyrrolidine dithiocarbamate inhibition of NF‐κB activation , 1999 .

[23]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[24]  R. Kao,et al.  Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[25]  I. Rodger,et al.  Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.

[26]  K. Channon,et al.  Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. , 1998, Circulation research.

[27]  H. Matsubara,et al.  Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. , 1998, Circulation.

[28]  J. Guerrero,et al.  Modulation of ventricular function through gene transfer in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[30]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[31]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[32]  E. Zandi,et al.  The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. , 1997, Cell.

[33]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[34]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[35]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[36]  L. Kedes,et al.  Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, and location of expression. , 1996, Journal of molecular and cellular cardiology.

[37]  R. Kao,et al.  Factors accounting for growth and atrophy of the heart. , 1976, Recent advances in studies on cardiac structure and metabolism.

[38]  A. Benchimol,et al.  RECENT ADVANCES IN STUDIES ON CARDIAC STRUCTURE AND METABOLISM , 1973 .

[39]  G. Breithardt,et al.  Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. , 2002, Cardiovascular research.

[40]  D. Ganten,et al.  NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats , 2000 .

[41]  D. Ganten,et al.  NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. , 2000, Hypertension.

[42]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[43]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .